These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 26079252)
21. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer. Amato RJ; Melnikova V; Zhang Y; Liu W; Saxena S; Shah PK; Jensen BT; Torres KE; Davis DW Urology; 2013 Jun; 81(6):1303-7. PubMed ID: 23622774 [TBL] [Abstract][Full Text] [Related]
22. Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking. Green BJ; Nguyen V; Atenafu E; Weeber P; Duong BTV; Thiagalingam P; Labib M; Mohamadi RM; Hansen AR; Joshua AM; Kelley SO Anal Chem; 2019 Aug; 91(15):9348-9355. PubMed ID: 31264404 [TBL] [Abstract][Full Text] [Related]
23. Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients. Thalgott M; Rack B; Eiber M; Souvatzoglou M; Heck MM; Kronester C; Andergassen U; Kehl V; Krause BJ; Gschwend JE; Retz M; Nawroth R BMC Cancer; 2015 Jun; 15():458. PubMed ID: 26051431 [TBL] [Abstract][Full Text] [Related]
25. Liquid biopsy: ready to guide therapy in advanced prostate cancer? Hegemann M; Stenzl A; Bedke J; Chi KN; Black PC; Todenhöfer T BJU Int; 2016 Dec; 118(6):855-863. PubMed ID: 27430478 [TBL] [Abstract][Full Text] [Related]
26. The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer. Pantel K; Alix-Panabières C Cancer Discov; 2012 Nov; 2(11):974-5. PubMed ID: 23093252 [TBL] [Abstract][Full Text] [Related]
27. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test. Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318 [TBL] [Abstract][Full Text] [Related]
28. Biomarkers in prostate cancer - Current clinical utility and future perspectives. Kretschmer A; Tilki D Crit Rev Oncol Hematol; 2017 Dec; 120():180-193. PubMed ID: 29198331 [TBL] [Abstract][Full Text] [Related]
29. Evolution of the Liquid Biopsy in Metastatic Prostate Cancer. Moreno JG; Gomella LG Urology; 2019 Oct; 132():1-9. PubMed ID: 31207303 [TBL] [Abstract][Full Text] [Related]